Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 4 | / | 2019 | |||||||||
| Data sporządzenia: | 2019-10-04 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| List of Shareholders representing at least 5% of the number of votes at the Annual General Meeting of the Shareholders on October 3, 2019 | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 % | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc, (“the "Company”,"the Issuer") hereby informs that the entities named below were shareholders representing at least 5% of the number of votes at the Annual General Meeting of Shareholders held in Livingston, New Jersey, USA, on October 3, 2019 “the Meeting" - Milestone Scientific Inc.- the shares held in the Company vested in Milestone Scientific the right of 21,633,084 votes at the Meeting, which accounted for 100% of the votes of the Shareholders present at the Meeting and for 98.33% of the total number of votes. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2019-10-04 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
Źródło:Komunikaty spółek (ESPI)
